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Summary 
 
Pre-pregnancy obesity, defined as a body mass index (BMI) greater than or equal 
to 30 kg/m2, can have adverse effects on the health of newborns and can also lead 
to metabolic, cardiovascular and neurological diseases in the offspring as they 
grow older. In the area of fetal origins and disease in adult life, a large number of 
studies have reported a critical role for maternal weight and metabolism before or 
during gestation in shaping the health of their offspring. Maternal obesity is 
recognised as a major modifiable contributor to obesity and metabolic syndrome 
in offspring, but the underlying factors remain unclear. The fetal autonomic 
nervous system (ANS) is subject to programming during developmental periods 
and is considered one of the processes by which early programming of disease can 
take place.  
 
The main goal of the present work was to use the fetal heart rate (HR) and heart 
rate variability (HRV) as proxies for the fetal ANS to study the effects of metabolic 
and anthropometric maternal (MAM) parameters before and during gestation on 
the fetuses of healthy, normoglycemic mothers. A total of 184 women in their 
second/third trimesters of uncomplicated pregnancies were included in this study. 
Pre-pregnancy BMI and maternal weight gain during pregnancy were recorded. In 
a subsample (n = 104), maternal insulin sensitivity was measured during an oral 
glucose tolerance test. Fetal HR and HRV were determined by magnetic recording 
in all subjects. The influence of pre-pregnancy BMI, maternal weight gain and 
maternal insulin sensitivity on fetal HR and HRV was evaluated. Associations 
between MAM parameters and maternal HR and HRV were also assessed. ANCOVA, 
partial correlation and mediation analysis were applied, all of which were adjusted 
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for gestational age, gender and parity. A regression on fetal HR using a machine 
learning approach was tested to explore which maternal factor is the driving factor 
programming the fetal ANS. Four models were tested: Linear regression, 
Regression Tree, Support Vector Machine and Random Forest.  
 
The fetal HR was higher in fetuses of mothers with high pre-pregnancy BMI 
(overweight/obese) than in mothers with normal weight. The fetal HRV was lower 
in mothers with high weight gain than in mothers with normal weight gain. The 
fetal HR was negatively correlated with maternal weight gain and maternal insulin 
sensitivity. Pre-pregnancy BMI was positively correlated with fetal high frequency 
and negatively correlated with low frequency and the low to high frequency ratio. 
Maternal weight gain was associated indirectly with birth weight through fetal HR, 
while maternal insulin sensitivity was associated with fetal HR through fetal HRV. 
Separately, fetal HRV was associated with birth weight through the fetal HR. The 
Random Forest ensemble tree-based model outperformed linear regression as the 
fetal HR regression model. Fetal HR can be predicted using the following nine 
relevant variables (sorted from the most important to the least important): pre-
pregnancy BMI, gender, maternal fasting insulin, maternal insulin sensitivity, 
gravidity, maternal age, maternal fasting glucose, gestational age and maternal 
weight gain. Pre-pregnancy BMI appeared to be the major factor predicting fetal 
HR. In conclusion, the fetal ANS is sensitive to maternal metabolic and 
anthropometric influences, and particularly maternal weight before pregnancy. 
These findings support the concept of the “Developmental Origin of Health and 
Disease” and increase our knowledge about the importance of the intrauterine 
environment in the programming of the ANS and the possible programming of 
disease in later life.   
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Chapter 1 
General introduction 
Obesity, defined as a body mass index (BMI) greater than or equal to 30 kg/m2, has 
become a worldwide epidemic and continues to rise (WHO, 2018) . Some studies 
have reported that maternal obesity might expose women’s offspring to long-term 
health effects, including obesity (Alfaradhi & Ozanne, 2011; Drake & Reynolds, 
2010; Lecoutre & Breton, 2015; Poston, Harthoorn, & Van Der Beek, 2011; 
Wankhade, Thakali, & Shankar, 2016). Taking a closer look at the societal 
“overnutrition” trend, infants of women with obesity often have higher birth 
weights and a greater risk of obesity in later life when compared with infants born 
to women without obesity (Godfrey et al., 2017; Taylor & Poston, 2007). Women 
with obesity before pregnancy also appear to have offspring with obesity in 
childhood and adulthood (Drake & Reynolds, 2010). Moreover, recent meta-
analyses suggest that excessive maternal weight gain can predispose the offspring 
to develop obesity in later life (Leonard, Petito, Rehkopf, Ritchie, & Abrams, 2017; 
Mamun, Mannan, & Doi, 2014; Nehring, Lehmann, & von Kries, 2013).  
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For the past thirty years, epidemiological studies have shown that diseases are 
programmed during early life development and involve interactions between 
inheritance, both genomic and development, and environment (Gluckman, Hanson, 
& Buklijas, 2010; Hanson & Gluckman, 2014). A study of the Dutch Hunger Winter 
victims was the earliest to link early life nutrition to later obesity (Ravelli, Stein, & 
Susser, 1976). The researchers found that offspring born to women exposed to 
famine in early pregnancy were more likely to become obese in later life. The 
emergence of the fetal programming theory emerged from a later series of 
epidemiological studies by David Barker and colleagues in 1986 and onwards 
(Barker & Osmond, 1986; Barker, Osmond, Golding, Kuh, & Wadsworth, 1989; 
Barker, Osmond, Winter, Margetts, & Simmonds, 1989). They proposed that 
maternal undernutrition during pregnancy might interrupt metabolic signalling in 
fetuses and may cause dysfunction of the metabolic systems controlling fetal food 
intake and storage, thereby resulting in cardiovascular diseases in adulthood 
(Barker, 1995; Godfrey & Barker, 2001). Further studies broadened this concept by 
including additional stressors like maternal stress and environmental chemical 
exposures, and provided further evidence for the possibility that a variety of 
metabolic, cardiovascular and neurological diseases can be triggered during fetal 
development (Barouki, Gluckman, Grandjean, Hanson, & Heindel, 2012; Reynolds, 
2013). This theory is known today as DOHaD, short for “Developmental Origins of 
Health and Disease” (Gluckman & Hanson, 2006; Suzuki, 2018).  
 
Overall, these previous findings suggest that maternal weight and metabolism 
could shape offspring development. Despite many studies reporting evidence of 
unfavourable outcomes in offspring of mothers with obesity and excessive 
maternal  
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weight gain, the possible underlying processes that could link changes in maternal 
weight and metabolism to the health of offspring are not well understood.  
 
Autonomic nervous system (ANS) is the main system responsible for energy 
balance and regulation of body weight (Hall, 2015; Landsberg, Saville, & Young, 
1984; Young, 2002). A comparably low HRV, is a common feature of childhood and 
adulthood obesity, indicating an imbalance in the ANS (Thayer, Yamamoto, & 
Brosschot, 2010). Adults with low birth weight tend to have a high resting pulse 
rate (Phillips & Barker, 1997). These observations suggested that the programming 
of the ANS is established during fetal development and might be one of the system 
involve in the disease development in adulthood. Also, Young suggested that 
programming of ANS in utero is linked to the development of obesity (2002). 
Although limited data are available relating birth weight and ANS in adults (Phillips 
& Barker, 1997; Weyer, Pratley, Lindsay, & Tataranni, 2000), more studies have 
emerged showing an association of undernourishment during fetal development 
and fetal HRV, an indirect measure of fetal ANS. Several studies have reported a 
lower fetal HRV in growth-restricted fetuses than in normal fetuses (Nijhuis et al., 
2000; Schneider, Fiedler, Liehr, Kahler, & Schleussner, 2006). Conversely, fetuses 
of women with gestational diabetes mellitus (GDM), also had lower postprandial 
fetal HRV (Fehlert et al., 2016). These researchers proposed an impaired 
development of the ANS in fetuses exposed to hyperglycaemia. GDM and maternal 
insulin resistance also have a known relationship with the postprandial response 
in the fetal central nervous system (Linder et al., 2014; Linder et al., 2015), while 
pre-pregnancy obesity appears to have long-term impacts on offspring 
neurodevelopment (Casas et al., 2013; Hinkle et al., 2012). Furthermore, women 
with higher pre-pregnancy BMI also have higher perinatal insulin resistance 
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(measured from cord blood), suggesting a relationship within utero development 
of peripheral insulin resistance (P. M. Catalano, Presley, Minium, & Hauguel-de 
Mouzon, 2009), which could potentially program the fetal metabolic phenotype.  
 
Given the potential for a negative effect of early life metabolic influences on the 
development of fetal ANS, and coupled with the fact that maternal weight or 
weight gain can, at least to a point, be modified, this modifiable risk factor for 
impairment in fetal ANS is particularly worthy of study. The objective of this thesis 
was to broaden the current knowledge of the potential role of intrauterine 
challenges linked with maternal obesity in fetuses of healthy mothers on the 
development of fetal ANS – a process by which early programming of disease 
might take place. Therefore, the research aim of this study was to explore the 
relationship between various metabolic and anthropometric maternal (MAM) 
parameters before and during gestation and the fetal HR and HRV in healthy 
pregnancies. Specifically, various analysis methods were used to investigate the 
association between maternal factors (pre-pregnancy BMI, maternal weight gain 
and glucose metabolism during the fasting state), and the fetal HR and HRV. The 
existence of the inter-relationships between MAM parameters, fetal HR, HRV and 
neonatal birth weight were evaluated by mediation analysis. Gestational age and 
parity were added as covariates in the analysis of fetal HRV, and a gender effect 
was tested as a potential control factor. The MAM parameters and maternal HRV 
were then used as features in the prediction of fetal HR using machine learning 
regression models. Fetal HR and HRV based on fetal magnetocardiograms (MCGs) 
were examined in a large sample of subjects. High pre-pregnancy BMI, excessive 
maternal weight gain and maternal insulin resistance in healthy pregnancies were 
expected to alter fetal HR and HRV. 
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1.1. The autonomic nervous system  
The ANS regulates the internal body functions that maintain body homeostasis 
(Squire et al., 2008; Wehrwein, Orer, & Barman, 2016). Its nerve cells leave the 
spinal cord and brainstem and connect to all the major organs and glands to either 
inhibit or stimulate their activity (Hall, 2015). The ANS is composed of two 
subsystems: the sympathetic nervous system (SNS) and parasympathetic nervous 
system (PNS). Functionally, each system is dominant under certain conditions. The 
SNS is stimulated during stressful situations and elicits what are known as “fight-
or-flight” responses. The PNS is responsible for quiet “rest-and-digest” activities, 
and opposes the effects of the SNS. Overall, the PNS conserves and stores energy 
to regulate basic body functions.  
 
The main transmitter produced and released by sympathetic post-ganglionic 
neurones is norepinephrine, whereas the parasympathetic post-ganglionic 
neurones produce and release acetylcholine. This difference in neurotransmitters 
causes the different functions between SNS and PNS (Squire et al., 2008). Figure 
1.1 shows the connection of SNS and PNS to organs in human body. The ANS 
consists of a series of two neurones that conduct impulses away from the central 
nervous system (CNS). The axon of the first neuron (called a pre-ganglionic neuron) 
synapses with a second neuron within an autonomic ganglion located outside the 
CNS. The axon of the second neuron (called a post-ganglionic neuron) extends 
from autonomic ganglion synapses to an organ tissue. The ANS conducts impulses 
from pre-ganglionic to the post-ganglionic neuron to stimulate the organ. Most 
organs are innervated by both systems, but some are innervated by only the SNS. 
The organs, such as the heart, that receive dual innervation show opposing effects 
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of the SNS and PNS, where an increase in the activity of one system simultaneously 
decreases the activity of the other. This antagonistic effect allows for the precise 
control of a tissue's function, resulting in the state of activity of the organ. 
Dynamic interplay between both systems is important for body homeostasis as 
well as serving as a survival mechanism (Squire et al., 2008; Wehrwein et al., 2016). 
 
 
 
Figure 1.1 Autonomic nervous system and its two branches. Left: Sympathetic nervous 
system. Right: Parasympathetic nervous system. Image from Hall (2015) used by 
permission of Elsevier. 
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1.2. Autonomic control of the heart rate  
Baseline HR is controlled at an internal pace that is determined by the sinoatrial 
(SA) node, while the ANS controls the heart rhythm through the SNS and the PNS 
(Figure 1.2).  
 
 
Figure 1.2 Control of the heart by sympathetic and parasympathetic nerves. Image from 
Hall (2015) used by permission of Elsevier. 
 
SNS stimulation increases the HR, while PNS stimulation decreases the HR. The 
sympathetic nerves innervate the heart muscle throughout the atria and ventricles 
to provide higher pumping ability during stress (Hall, 2015; Squire et al., 2008). 
SNS stimulation releases norepinephrine at the nerve endings and increases the 
permeability to sodium and calcium ions. This causes a more positive resting 
potential of the heart cells at the SA node, thereby increasing the rate of self-
excitation, which then leads to an increase in HR. The vagus nerve mainly 
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innervates the heart at the SA node and the atrioventricular (AV) node. 
Parasympathetic stimulation releases acetylcholine at the vagal ending. This 
increases the permeability of the fiber membranes to potassium, thereby leading 
to a decrease in the resting membrane potential of the SA node to a lower value 
than usual. The time needed to reach the self-excitation rate increases, resulting 
in slower heart beats. Parasympathetic activation to change the heart rate takes 
around 1.5 seconds, while sympathetic activation takes longer, around 24 seconds 
(Berntson et al., 1997). The differences in the speed and frequency of 
parasympathetic and sympathetic activation serves as the basis of spectral 
analysis of fetal HRV, which will be discussed in the next section. 
 
1.3. Fetal heart rate and heart rate variability 
The activity of the ANS can be estimated noninvasively by HRV analysis (Akselrod 
et al., 1981; Malik, 1996; Sayers, 1973). This analysis is based on consecutive heart 
beat variations of sinus origin. The interval between the R wave onsets of 
electrocardiogram (ECG) or MCG traces are typically used as the reference wave 
(i.e. the RR interval) to mark the heart beats since this has the largest amplitude 
compared to the neighbouring P, Q, S and T waves. A standard for HRV 
measurement, interpretation and clinical use was established in 1996 (Malik, 
1996). The analysis involves deriving time and frequency domain parameters using 
geometrical and nonlinear methods. The time and frequency domain analyses were 
the methods used in this dissertation.  
 
Fetal HR and HRV can be assessed noninvasively with magnetic sensors (Brändle 
et al., 2015; Fehlert et al., 2016; Van Leeuwen, Lange, Bettermann, Gronemeyer, & 
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Hatzmann, 1999; Wakai, 2004) or electrodes (David, Hirsch, Karin, Toledo, & 
Akselrod, 2007; Karin, 1994). These methods provide the necessary temporal 
resolution for reliable assessment of fetal HRV measures. In 1960, Hon introduced 
fetal HR monitoring, and he was the first to describe HRV as a clinical application 
in relation to maternal contractions (Hon, Reid, & Hehre, 1960). Later, he showed 
that fetal distress was preceded by alterations in fetal HRV even before the changes 
in the mean HR could be observed (Hon & Lee, 1963). Since then, fetal HRV has 
gained interest, particularly in pathologic conditions like intrauterine growth 
restriction (IUGR) pregnancy and preterm birth (Aziz, Schlindwein, Wailoo, Biala, 
& Rocha, 2012; Huhn et al., 2011; Schneider et al., 2006; Sriram et al., 2013). Fetal 
HR has been used as standard clinical procedure for fetal monitoring (Banta & 
Thacker, 1979; Dawes, Moulden, & Redman, 1996; Jenkins, 1989; Macones, 
Hankins, Spong, Hauth, & Moore, 2008) and is known as an important indicator of 
fetal well-being.   
 
The normal fetal HR ranges from 120 to 160 beats per minute (bpm) (Pildner von 
Steinburg et al., 2013). The regulation of the fetal HR is mainly driven by 
parasympathetic and sympathetic innervation (David et al., 2007). The 
synchronization of PNS and SNS neural activity at the SA node is thought to 
increase or decrease the fetal HR. Decreases in fetal HR and increases in HRV 
indicate that parasympathetic activity is dominant, while the opposite changes 
occur when sympathetic activity is dominant. Such changes in both HR and HRV 
have been used as indicators of fetal ANS maturation (Schneider et al., 2018; 
Schneider et al., 2009). In healthy developing fetus, the fetal HR decreases and HRV 
increases in a more complex pattern throughout gestation (Pildner von Steinburg 
et al., 2013; Serra, Bellver, Moulden, & Redman, 2009; Van Leeuwen et al., 1999; 
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Wakai, 2004). In the normally developing fetal ANS, the regulation of the HR is 
mostly under the control of SNS because the maturation of the PNS mainly occurs 
after birth. Only in the third trimester, starting from 31 weeks of gestation, does 
the parasympathetic regulation start to increase (Pildner von Steinburg et al., 2013; 
Van Leeuwen, Cysarz, Edelhauser, & Gronemeyer, 2013; Wakai, 2004).  
 
The response of fetal HR and HRV could be influenced by several other factors. 
Fetal HR and gestational age have been suggested to have strong influence on the 
fetal HRV (Lange, Van Leeuwen, Geue, Hatzmann, & Gronemeyer, 2005). In 
addition, gender also has an influence on the fetal HR, even though some 
inconsistencies exist in the reported findings. For example, no differences in fetal  
gender were detected at any gestational age (Bracero et al., 2016; Druzin, Hutson, 
& Edersheim, 1986; Fleisher, DiPietro, Johnson, & Pincus, 1997; Genuis, Genuis, & 
Chang, 1996; Lange et al., 2005; Ogueh & Steer, 1998), whereas DiPietro described 
differences in fetal HR at the second and third trimester, with a faster HR in female 
than in male fetuses (2015).  
 
The following is a short overview of the current state of research regarding the 
influence of maternal weight and metabolism on fetal HR and HRV: Earlier studies 
on fetal HRV in human fetuses were mainly performed in studies on maternal 
undernutrition (Bekedam, Visser, Mulder, & Poelmann-Weesjes, 1987; Nijhuis et al., 
2000; Schneider et al., 2006; Sriram et al., 2013). Later studies reported fetal HRV 
in pregnancies associated with diabetes and GDM (Costa, Nomura, Reynolds, 
Miyadahira, & Zugaib, 2009; Fehlert et al., 2016; Sirico, Sarno, Zullo, Martinelli, & 
Maruotti, 2019; Tincello, White, & Walkinshaw, 2001). Data are limited that relate 
maternal obesity and fetal HRV. To my current knowledge, only one study has 
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investigated the effect of maternal obesity on fetal HRV (Voegtline, Costigan, 
Henderson, & DiPietro, 2016). These researchers found lower fetal HRV and lower 
fetal HR acceleration in the fetuses of women with pre-pregnancy obesity than in 
the fetuses of women with normal weight, suggesting an impairment in fetal 
cardiac and motor development. One study tested the relationship between 
maternal insulin resistance and maternal inflammation with fetal HRV, but found 
no association (Dewi et al., 2017). Another study found a positive association 
between pre-pregnancy BMI and fetal HRV, the low to high frequency ratio (Ojala 
et al., 2009).   
 
1.4. Fetal magnetoencephalography  
Fetal magnetoencephalography (fMEG) is a non-invasive technique for recording 
magnetic fields generated by electrical currents in human tissue, with special 
adaptation for fetal and neonatal measurements (Preissl, Lowery, & Eswaran, 
2005). The method allows the simultaneous recording of fetal brain 
(magnetoencephalography, MEG) and fetal heart (MCG) signals through a sensor 
array fit onto the mother‘s abdomen. MEG for fetal measurement was first 
reported in 1976 to measure fetal heart signals (Hukkinen et al., 1976) and was 
later used by Blum to record fetal evoked brain responses (Blum, Saling, & Bauer, 
1985). The fetal adapted systems were built later. The high temporal resolution of 
the fetal heart signal recorded by fMEG device allows the investigation of the fetal 
ANS through HRV analysis (Brändle et al., 2015; Fehlert et al., 2016; Sriram et al., 
2013). Fetal heart signal amplitudes range from 1 to 10 pico Tesla and are stronger 
than the fetal brain signals, which range from 10 to 80 femto Tesla (Vrba, 
Robinson, McCubbin, Murphy, et al., 2004).  
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1.5. Goals and hypotheses 
The specific goal of this dissertation was to provide insight into the relationship 
of variations in MAM parameters—specifically pre-pregnancy BMI, maternal weight 
gain and maternal insulin sensitivity—and the ANS during fetal development. A 
second goal was to evaluate whether the associations of MAM and birth weight are 
mediated through the fetal ANS. A third goal was to predict fetal HR using 
regression-based machine learning algorithms from MAM parameters and 
maternal HRV as features. 
 
In this dissertation, the following hypotheses were tested: 
1. High pre-pregnancy BMI, excessive maternal weight gain and maternal 
insulin resistance in healthy pregnancies are associated with an increase in 
fetal HR and/or a decrease in fetal HRV.  
2. Fetal ANS is one of the processes linking MAM and weight at birth.  
3. Among the MAM parameters, pre-pregnancy BMI (as weight before 
pregnancy) has a stronger role in the programming of fetal ANS.  
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Chapter 2 
Material and methods 
2.1. Study population  
An MCG was recorded for the duration of 15 minutes in 184 pregnant women. In 
six of the recordings, the MCG could not be extracted due to the low signal to noise 
ratio, resulting in a total number of 178 included datasets. In a subsample 
comprising 104 participants, an oral glucose tolerance test (OGTT) was performed. 
For the anthropometric and metabolic characteristics of the participants, see the 
Results and Table 3.2.  
 
Written informed consent was received from participants prior to all 
measurements. The Ethics Committee of the Medical Faculty of the University of 
Tübingen approved the study plan. Self-reported health information was collected, 
including past medical history, current health condition, maternal age, parity, 
gravidity and height, as well as body weight before pregnancy and at the time of 
measurement. Inclusion criteria included uncomplicated pregnancies and normal 
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perinatal outcomes. Exclusion criteria included hypertension, cardiovascular 
disease, diabetes mellitus and GDM. 
 
Pre-pregnancy BMI is a measure of preconception body mass index in units of 
kg/m2. Based on the BMI category from the World Health Organization (WHO, 
2000), participants were assigned to four pre-pregnancy BMI groups: underweight 
(UW, BMI < 18.5 kg/m²; n = 9), normal weight (NW, BMI 18.5–24.9; n = 120), 
overweight (OW, BMI 25.0–29.9; n = 32) and obese (OB, BMI ≥ 30.0; n = 17). 
 
Maternal weight gain, which is a measure of weight gain during gestation (in 
kg/week) in the 2nd and 3rd trimester, was calculated according to the following 
formula: 
 
 Maternal weight gain
=
Weightduring pregnancy(kg) − Weightbefore pregnancy(kg) − 1.25 kg
Gestational age (weeks) − 12 weeks
 
 
For the weight gain during the 1st trimester (12 weeks), participants were assumed 
to gain the average recommended weight of 1.25 kg (Rasmussen & Yaktine, 2009) 
(see Table 2.1). This value was subtracted from the total weight gain and divided 
by the number of gestational weeks the pregnancy had progressed in the 2nd and 
3rd trimesters (gestational age during visit minus 12 weeks for the 1st trimester).   
 
On the basis of the Institute of Medicine recommendations for maternal weight 
gain in the respective pre-pregnancy BMI groups (Rasmussen & Yaktine, 2009), the 
participants were assigned to three maternal weight gain groups: below the 
recommended weight gain (Low; n = 66), within the recommended weight gain 
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(Normal; n = 53) and above the recommended weight gain (High; n = 59). Table 2.1 
summarises the recommendations and absolute values for maternal weight gain 
according to the pre-pregnancy BMI and maternal weight gain groups.  
 
 
 
2.2. Laboratory measurements and calculations  
In a subsample comprising 104 participants an OGTT (75 g glucose challenge) was 
performed. Blood samples were obtained at three time points: before glucose 
ingestion and 60 and 120 minutes after the challenge. Calculations and laboratory 
procedures of the blood measures are detailed in previous publications (Linder et 
al., 2014; Linder et al., 2015). Maternal fasting blood glucose and insulin were 
determined using the ADVIA 1800 autoanalyzer (Siemens Healthcare Diagnostics) 
and the ADVIA Centaur XP immunoassay system (Siemens AG), respectively. 
Maternal ISI is defined as the ability of insulin to increase glucose uptake to 
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maintain glucose homeostasis (Wilcox, 2005). Maternal ISI were calculated in units 
of µmol kg–1 min–1 pmol/l, according to the formula Stumvoll (2001):  
 
Maternal insulin sensitivity
= 0.156 − 0.0000459 · Ins120min − 0.000321 · Ins0min − 0.00541 · Glu120min 
 
Ins120min and Glu120min  are the insulin level and the glucose level, respectively at 
120 minutes after the glucose challenge and Ins0min is the insulin level at the 
fasting state.  
 
2.3. Data acquisition  
Figure 2.1 shows a flow chart from fMEG data acquisition to MCG data processing 
and HRV analysis. All MCG measurements were performed with the SARA (SQUID 
Array for Reproductive Assessment, VSM MedTech Ltd., Port Coquitlam, Canada) 
system in the fMEG Center at the University of Tübingen; this system was 
specifically developed for fetal measurements. The system consists of 156 primary 
magnetic sensors and 29 reference sensors. The primary magnetic sensors are 
distributed over a concave array that is shaped to match the form of the gravid 
abdomen (Figure 2.2). During the measurements, the mother leans forward in a 
comfortable resting position, with minimal pressure on the abdomen. The system 
is located in a magnetically shielded room (Vakuumschmelze, Hanau, Germany) to 
attenuate external magnetic fields, and it allows for simultaneous recording of 
maternal and fetal MCG signals (Preissl, Lowery, & Eswaran, 2004). Spontaneous 
MCG without any stimulation was recorded continuously for a period of 15 
minutes at a sampling frequency of 610.4 Hz.  
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Figure 2.1 Flow chart from fMEG data acquisition to MCG data processing and HRV analysis 
 
 
Figure 2.2 Left: Schematic of a pregnant woman on the fetal MEG device with SQUID coils 
that allow recording of biomagnetic fields; for example, fetal brain and fetal heart activity. 
Right: a pregnant mother is seated on the fetal MEG device. © University Hospital Tübingen 
 
 
 18  |    Ma t e r i a l  an d  me t ho ds  
 
2.4. MCG detection and RR intervals extraction 
Signals recorded from the fetal MEG device contain magnetic fields generated by 
electrical activity from various biological sources in the maternal body. Two major 
signals come from the maternal and fetal hearts—the maternal MCG and fetal 
MCG. For the analysis of maternal and fetal HRV, time differences between 
consecutive R waves (RR intervals) were acquired as an input signal and extracted 
from the maternal MCG and fetal MCG.   
 
The RR intervals of the maternal and fetal heart signals were extracted using the 
following methods: First, the maternal MCG was detected and marked with a 
template matching technique (Vrba, Robinson, McCubbin, Lowery, et al., 2004) or 
with adaptive Hilbert transformation (Ulusar et al., 2009). The maternal RR 
intervals were extracted and the maternal MCG was attenuated by signal space 
projection (McCubbin et al., 2006; Vrba, Robinson, McCubbin, Lowery, et al., 2004). 
After removal of the maternal MCG, the fetal MCG was marked in the resulting 
dataset and the fetal RR intervals were obtained by identical methods. Before 
extraction of the maternal RR intervals, the data were high-pass filtered at 0.5 Hz 
and the fetal RR data were extracted after application of a band-pass filter between 
1 and 50 Hz. Figure 2.3 shows the overlaid time series of all MEG channels before 
and after the maternal MCG extraction. Image in Figure 2.3 from Preissl et al. (2004) 
is used by permission of Elsevier.  
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Figure 2.3 Upper: a 15 second time series of all overlaid MEG channels with visible maternal 
MCG (marked by “M”) and fetal MCG signals (marked by “F”). Lower: the resulting time 
series with fetal MCG as the main component, after the extraction of maternal MCG. Image 
from Preissl et al. (2004) used by permission of Elsevier. 
  
2.5. HRV analysis  
The analyses, including pre-processing of RR time series and short-term HRV 
analysis in both the time and frequency domains, were developed and performed 
by in-house routines in MATLAB (Mathworks, Inc., Natic, MA, USA). The in-house 
routines were based on existing standard approaches and tailored for use with 
fetal MEG data on our system. The details of the techniques are described in the 
following sections.  
 
2.5.1. Pre-processing of the RR time series  
The RR interval, determined from consecutive R waves, is shown in Figure 2.4.  
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Figure 2.4 An MCG segment of overlaid all MEG channels containing 4 fetal heart beats 
showing the extraction of beat-to-beat interval from consecutive R waves. T is the time 
corresponding to the RR.  
 
The RR time series of an MCG segment containing 𝑖 beats is given by: 
𝑅𝑅𝑖 = 𝑇𝑖+1 − 𝑇𝑖 
where 𝑅𝑅𝑖 is the 𝑖𝑡ℎ RR interval in the segment,  𝑇𝑖 is the time of the 𝑖𝑡ℎ beat occurs. 
The HRV is defined as the variation in the beat-to-beat interval during sinus 
rhythm. Therefore, any cardiac fluctuations that are not caused by the sinus node 
(known as ectopic beats) need to be excluded from the HRV analysis. The pre-
processing steps were therefore intended to filter out noise effects and minimize 
the number of incorrectly detected R-peaks due to the occurrence of ectopic beats. 
Ectopic beats were detected and replaced by an adaptive filtering method (Wessel 
et al., 2000). The process is illustrated in Figure 2.5.  
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Figure 2.5 Correction of ectopic beats in a segment of RR time series. Upper: original RR 
time series. Lower: resulting time series after ectopic beat replacement using adaptive 
filtering.  
 
A detrending method called “smoothness prior detrending”, as proposed by 
Tarvainen et al. (2002), was applied to eliminate the unwanted low frequency 
trends in the RR time series. Detrending is a common pre-processing step applied 
in HRV analysis. It was performed through high-pass filtering the non-stationary 
trends to minimize the non-stationarities within the RR time series. The 
stationarity of the RR time series is required for power spectral density estimation. 
Trends in physiological signals, like HR signals, contain complex components and 
strongly affect the low frequency components (Colak, 2009; Yoo & Yi, 2019). A 
lambda value of 500 was used to remove the unwanted low-frequency trend 
components. This value was chosen to have a high pass filter with cut-off 
frequency of less than 0.04 Hz (the lower limit of the low frequency band) to avoid 
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distorting the frequency band of interest. Figure 2.6 shows the detrending of an 
RR time series.  
 
Figure 2.6 Detrending a segment of an RR time series. Upper: original RR time series. The 
red line shows the low-frequency trend component of the time series. Lower: resulting time 
series after removal of the trends by “smoothness prior detrending”.  
 
The short-term HRV analysis was performed according to a standard approach 
(Malik, 1996) in both time and frequency domains. For maternal HRV, the 15-
minute data were segmented into 5-minute segments to reduce the non-
stationarity, and the HRV was computed for each segment. The average of the 
HRVs of the three periods was then used in the analysis. Since the fetal HR is 
usually much higher than the maternal HR, shorter segments were used for fetal 
data to reduce the issue of non-stationarity. Based on the procedure by Schneider 
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et al. (2009), the fetal HRV was analyzed from segments of 256 fetal heart beats. 
Assuming an average fetal HR of 140 bpm, a segment was roughly 2 minutes long.  
 
2.5.2. Time domain HRV measures  
Time domain analysis estimates the changes in the HR time series. For time 
domain measures, we calculated the mean HR in beats per minute (bpm). The 
variability within the RR time series was investigated by including the standard 
deviation of RR intervals (SDNN) and the root mean square difference of successive 
RR intervals (RMSSD) in the analysis.   
 
2.5.3. Frequency domain HRV measures  
Frequency analysis estimates the fluctuation of HR at different frequencies. In the 
frequency domain, the power spectral density was estimated using fast Fourier 
transform (FFT), based on Welch’s method. To calculate the FFT, the RR interval 
time series has to be transformed into an equidistant set of data points. Prior to 
the analysis, the unevenly sampled RR intervals were resampled with cubic spline 
interpolation at the resampling frequency of 4 Hz. This 4 Hz sampling frequency 
is sufficient to satisfy the Nyquist criterion to avoid the aliasing effect. The steps 
for performing FFT using Welch’s method consist of partitioning the time series 
data into overlapping windows, computing the periodogram for each window 
separately, and then averaging the periodogram segments to estimate the power 
spectrum. The segments overlapping by 50% and the Hamming window were 
applied to each data segment of 512 points in size (length of the Discrete Fourier 
Transform) before the computation of the periodogram. Welch's method was 
implemented using the “pwelch” function in MATLAB.  
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For maternal HRV, the spectral components of the different frequency bands 
typically used for adults (Malik, 1996) were evaluated: low frequency (LF: 0.04 to 
0.15 Hz), and high frequency (HF: 0.15 to 0.40 Hz). For fetal HRV, the respiratory 
motion of the fetus is reported to occur at a different frequency range than that 
of adults. Therefore, the frequency bands proposed by David et al. (2007) were 
used for HRV analysis in the fetus (LF: 0.08 to 0.2 Hz and HF: 0.4 to 1.7 Hz). The 
frequency components were expressed in absolute (LF and HF) as well as 
normalized (LFn and HFn) measures. SDNN, LF and LFn reflect both sympathetic 
and parasympathetic activity, while RMSSD, HF and HFn are assumed to be 
influenced by parasympathetic activity only. The LF/HF ratio reflects the balance 
between sympathetic and parasympathetic activity (David et al., 2007; Groome, 
Mooney, Bentz, & Wilson, 1994; Malik, 1996). The time and frequency domain 
parameters, with their formulas and their assumed influence of the ANS branches, 
are summarized in Table 2.2.   
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2.6. Regression analysis using machine learning 
Many studies have been performed to understand the behaviour of the fetal ANS 
and gain insight into neurodevelopment and fetal maturation (DiPietro, Costigan, 
Shupe, Pressman, & Johnson, 1998; DiPietro et al., 2015; Schneider et al., 2018). 
Multiple factors are assumed to contribute to the development of the fetal ANS, 
but the actual factors involved and how they interact remain to be established 
(DiPietro et al., 2015; Samuelsson et al., 2010; Young, 2002, 2006). Studies using 
fetal HRV indices themselves are now increasingly adopting machine learning. For 
example, Random Forest, an ensemble tree-based method, was used in the 
assessment of fetal maturation (Tetschke, Schneider, Schleussner, Witte, & Hoyer, 
2016). In another study, Support Vector Machine was used for detecting fetal 
distress (Warmerdam et al., 2018). 
 
Regression analysis is an approach for modelling the relationship between a 
continuous response and another set of regressor variables (also called 
independent variables). A regressor can be one continuous variable (known as 
single regression) or more variables (known as multiple regression). In a complex 
system like fetal ANS, the outcome most likely depends on multiple input 
variables. We conducted multiple regressions to examine whether fetal HR (as 
proxy of fetal ANS) is a function of multiple factors.  
 
Specifically, we used a machine learning approach to relate various maternal 
factors with the fetal HR to obtain insight into the possible factors driving fetal 
ANS behaviour. To avoid overlooking factors that might contribute to the ANS 
development, we included several maternal anthropometric parameters (for 
example, height and age) at the beginning of the analysis and then excluded the 
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factors that did not contribute to the model. The hypothesis was that the fetal 
ANS, operationalized as fetal HR, can be represented with a non-linear model and 
is driven by multiple maternal factors (for example, MAM and maternal ANS). The 
following techniques with non-linear functions were deemed as potentially 
beneficial and were applied: Random Forest and Support Vector Machine. Thus, 
this regression analysis sought to extract patterns from multiple maternal factors 
that are potentially useful for characterizing fetal ANS. The findings can provide 
knowledge about potential factors involved in the complex ANS process to better 
understand the developmental programming of the fetal ANS and its relationship 
with the weight at birth. 
 
In designing a model of fetal ANS, several supervised learning algorithms were 
used to perform the regression analysis. The workflow for building regression 
model of fetal HR is shown in Figure 2.7. The modelling, tuning and prediction for 
each algorithm was applied using the R “caret” package (M. Kuhn, 2008; Max Kuhn 
& Johnson, 2013). Caret, short for “Classification and Regression Training” is a 
streamline of multiple tools for modelling processes, including data splitting, 
feature selection and prediction.  
 
2.6.1. Data splitting and feature selection 
The subsamples containing 104 cases were included in the regression analysis. 
Testing the model on the unseen data will ensure that the model makes an 
unbiased prediction (James, Witten, Hastie, & Tibshirani, 2013; M. Kuhn, 2008). As 
an initial step, we randomly partitioned the dataset into two parts; “Training 
dataset” and “Testing dataset”. The training dataset is 70% of the data that were 
used for model training, evaluation and tuning (n = 73). The remaining 30% of the 
 
28  |    Ma t e r i a l  an d  me t ho ds  
 
data is the testing dataset (n = 31). The testing dataset was used for testing the 
prediction performance of the models. We used the function called 
“createDataPartition” in the R caret package (M. Kuhn, 2008) to perform the 
random splitting of the testing and training dataset.  
 
 
Figure 2.7 Workflow of the machine learning approach for building a regression model of 
fetal heart rate  
 
For the analyses, 11 clinical variables (pre-pregnancy BMI, maternal weight gain, 
maternal insulin sensitivity, maternal fasting glucose, maternal fasting insulin, 
gravidity, parity, maternal age, maternal height, gestational age during the 
measurement and fetal gender) and 8 maternal HRV variables (mean HR, SDNN, 
RMSSD, LF, HF, LFn, HFn and LF/HF) were included as regressors on fetal HR. 
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Abbreviations for descriptions of each variable are provided in Table 2.3. The 
model was trained according to three sets of features: 
1. Clinical variables consist of 11 features (upper part of Table 2.3).  
2. Maternal HRV consists of 8 HRV features (lower part of Table 2.3). 
3. Combined clinical/maternal HRV consists of 19 features. 
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2.6.2. Machine learning algorithms 
The Decision Tree, Random Forest (RF) and Support Vector Machine (SVM) 
algorithms were utilized to find one that best fit the data. The main concept of 
each algorithm is described in this section.  
 
Decision tree. Decision tree, introduced by Breiman, builds classification or 
regression models in the form of a tree structure (1984). The algorithm partitions 
a dataset into subsets through recursive partitioning. The partitioning process 
starts with a binary split and continues until no further splits can be made. The 
final result is a tree with various branches of variable lengths, called decision 
nodes and leaf nodes (also known as terminal nodes). The topmost node in a tree 
is a decision node (also known as a root node). It corresponds to the best predictor 
and has two or more branches. A leaf node contains a small subset of observations 
that represents a classification. Each leaf node can be presented as an “if-then” 
rule, and this makes the tree interpretable. For regression, the algorithm select the 
partition to minimize sum of squared error (James et al., 2013). As models with 
small trees are easier to interpret and produce decisions faster than large trees, 
the depth of the tree should be controlled (James et al., 2013). The regression tree 
was implemented using the “rpart” package provided within the R caret package 
(M. Kuhn, 2008; Therneau, Atkinson, & Ripley, 2019). 
 
Random forest. Random forest (RF) is a tree-based method that combines many 
decision trees into a single model. Individual predictions made by decision trees 
may not be accurate, but the predictions can be improved using combined decision 
trees; thus, the name “Random Forest” (James et al., 2013). The technique was 
created by Breiman (2001) and has a powerful performance in comparison to other 
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supervised learning methods (Lavecchia, 2015; Strobl, Malley, & Tutz, 2009). In 
addition, RF also provides a measure of the variable importance of each feature 
(Breiman, 2001). Especially in clinical research, this feature importance has been 
widely used as a selection tool to remove features that contribute less in the 
prediction process (Hapfelmeier & Ulm, 2013; Kursa, 2014; Touw et al., 2019). This 
is important because, in machine learning, a higher number of features in a model 
often leads to overfitting (Zhang & Ma, 2012). Therefore, RF is suitable due to its 
increased accuracy and its ability to overcome overfitting problems (James et al., 
2013). Each decision tree in the forest considers a random subset of input features 
in making predictions (Breiman, 2001). This increases diversity in the forest, 
leading to more robust overall predictions. For regression, the RF is formed by 
growing trees depending on a random vector of numerical values, and it takes an 
average of all the individual decision tree estimates (Zhang & Ma, 2012). To 
implement the RF algorithm, the package “randomForest” within the R caret 
package (M. Kuhn, 2008; Liaw & Wiener, 2018) was used with ntree = 1000 (ntree 
is the total number of trees in each forest) and mtry = default value (mtry is total 
number of randomly selected variables for each tree). The default value of mtry 
for regression is the total number of features divided by 3.  
 
Support vector machine. The goal of the support vector machine (SVM) algorithm 
is to find an optimum boundary that separates data points of one class from the 
other class (James et al., 2013). It is mainly used in classification problems, but for 
the case of regression, similar to the classification, it optimizes the generalization 
bounds given for regression (James et al., 2013). The boundary is known as a 
“hyperplane”. If the data are linearly separable with 2 dimensions, the best 
hyperplane is a straight line with the largest distance between two nearest data 
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points from either class. The distance between the hyperplane and the nearest data 
point from either set is known as a “margin”. These two data points, also known 
as “support vectors”, are the most critical elements, since the optimum hyperplane 
depends on their positions for dividing the two classes. For nonlinearly separable 
data, SVM transforms the data into a higher dimensional space where a hyperplane 
can be formed to separate the two classes. This transformation of data into a 
higher dimension is known as kernelling (James et al., 2013). Regression analysis 
using SVM was performed using Radial Basis Function kernel from the “kernlab” 
package provided in the R caret package (Karatzoglou, Smola, Hornik, & 
Karatzoglou, 2018; M. Kuhn, 2008; Schölkopf & Smola, 2001).  
 
2.6.3. Model training and validation  
Two metrics were used to evaluate the model performance: the mean absolute 
error (MAE) and the root mean squared error (RMSE). The MAE is the average of 
the absolute differences between predicted values and actual values. The formula 
for this metric is: 
MAE =  
1
𝑛
 ∑  |𝑦𝑖 − ?̂?𝑖|
𝑛
𝑖=1
 
where 𝑦𝑖 is the 𝑖𝑡ℎ actual outcome in the training dataset, ?̂?𝑖 is the model prediction.  
 
The RMSE is the average of the squared differences between predicted values and 
actual values. It can be obtained using: 
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RMSE =   √
1
𝑛
∑  (𝑦𝑖 −  ?̂?𝑖)2
𝑛
𝑖=1
 
 
Using the linear regression model as a baseline and based on the value of RMSE 
and MSE, we compared each model performance with the linear model.   
 
Due to the relatively small sample size for this approach, a robust resampling 
method called “k-fold cross-validation” was applied to maximize the usage of each 
data point (Max Kuhn & Johnson, 2013). The data were randomly partitioned into 
k subsets (k-folds) of approximately equal size. One subset (one fold) is reserved 
for model testing and all other subsets (k-1 folds) are used for evaluating the 
model performance. As suggested by Kuhn (2013), k = 10 was used to minimize 
bias and variance in the error estimation due to the small dataset. The partitioning 
of data was repeated 10 times, which resulted in n = 100 resamples to fit each 
model. The cross-validation error metrics were obtained using the following 
formula: 
𝑀𝐴𝐸𝑘  =  
1
𝑘
 ∑ 𝑀𝐴𝐸𝑖
𝑘
𝑖=1
 
 
𝑅𝑀𝑆𝐸𝑘  =  
1
𝑘
 ∑ 𝑅𝑀𝑆𝐸𝑖
𝑘
𝑖=1
 
 
where 𝑀𝐴𝐸𝑖 and 𝑅𝑀𝑆𝐸𝑖 are each the error of the 𝑖𝑡ℎ fold in the training dataset. The 
function “trainControl” in R caret package was used for setting the parameter of 
cross-validation. The random number generator was reset to a common seed using 
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the “set.seed” function to create the same folds of resampling datasets prior to 
each model fitting.  
 
2.6.4. Model testing, tuning and feature reduction 
The prediction performance of the model was tested using the “predict” function 
in the R caret package (M. Kuhn, 2008). The best model was further improved by 
tuning the model parameters, and the new tuned model was called the “tuned RF 
model”. In order to build a model with a small number of features, the features 
that effectively contributed to the prediction performance were additionally 
evaluated using the “varImp” function to obtain a variable importance score 
(Breiman, 2001; Genuer, Poggi, & & Tuleau-Malot, 2019; M. Kuhn, 2008). The 
variable importance score represents the increment in the sum of the squared 
error from the permutation of each feature (M. Kuhn, 2008). Features with a higher 
variable importance score are more important and make larger contributions to 
the model performance. We referred to the model with a lower number of features 
as the “tuned RF model with reduced features”.  
 
2.7. Statistical analysis 
All statistical analyses were performed with SPSS version 23 (IBM SPSS Statistics, 
NY, USA) and results with a significance level of P < 0.05 were regarded as 
statistically significant. Pearson’s correlations and partial correlations were 
performed to investigate the associations between MAM parameters and maternal 
and fetal HR and HRV. Pearson’s correlations were also performed to test the 
correlation between the predicted and the actual values of fetal HR in the machine 
learning models. A one-way analysis of covariance (ANCOVA) was performed 
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separately for the main factors pre-pregnancy BMI (4 levels), pregnancy weight gain 
(3 levels) and gender (2 levels). A one-way analysis of variance (ANOVA) was 
performed for the machine learning regression models (5 levels). A paired t-test 
was used in the case-control subsample between the matched groups of pre-
pregnancy BMI. Fetal HR and HRV were compared between pre-pregnancy BMI 
groups matched in gestational age, gender and parity. An independent t-test was 
used to compare the effect of fetal gender on fetal HR and HRV. For all analyses, 
except for Pearson’s correlations, the adjusted values with gestational age, gender 
and parity as covariates were reported. Data are presented as mean ± standard 
error of the mean (SEM). Bonferroni-Holm correction was applied for multiple 
comparisons and corrected significance levels were used. To explore the possible 
mediation relationship between MAM parameters and fetal HR, HRV and birth 
weight, a mediation analysis was performed with a simple mediation model using 
the PROCESS macro in SPSS (Hayes, 2017). The significance of mediation effects 
was determined using bootstrapping with 95% confidence intervals (Preacher & 
Hayes, 2008). Figure 2.8 illustrates a general model for testing mediation effects.  
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Figure 2.8 General model for testing mediation effects. Total effect = path c, the effect 
between the predictor and the outcome. Direct effect = path c’, the effect between the 
predictor and the outcome after including the mediator in the model. Indirect effect = path 
ab, is the multiplication between the effect of the predictor and the mediator (path a) 
multiplied by the effect of the mediator and the outcome (path b).  
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Chapter 3 
Results 
 
Section 3.1 presents the descriptive characteristics of study participants, followed 
by the results for the gender effect on fetal HR and HRV in section 3.2. Sections 
3.3 to 3.5 present the main results of the association between fetal HR, HRV and 
maternal weight factors, maternal glucose metabolism and birth weight. An 
overview of the analysis performed for the main results is provided in Table 3.1.  
 
Results in section 3.3, 3.4 and 3.5 presented in this chapter are published as: 
 
 
 
 
 
Mat Husin, H., Schleger, F., Bauer, I., Fehlert, E., Kiefer-Schmidt, I., Weiss, M., Kagan, 
K. O., Brucker, S., Pauluschke-Fröhlich, J., Eswaran, H., Häring, H. U., Fritsche, A. 
and Preissl, H. (2020). Maternal weight, weight gain and metabolism are associated 
with changes in fetal heart rate and variability. Obesity. 
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3.1 Study participants  
In the main sample of 184 subjects, the gestational age ranged between 26 and 38 
weeks (mean ± standard deviation, 30.37 ± 2.91), maternal age was 31.7 ± 5.3 years, 
pre-pregnancy BMI was 23.59 ± 3.96 kg/m2 and weight gain was 0.38 ± 0.21 
kg/week. Neonatal birth weight was 3387.9 ± 440.72 g. Detailed anthropometric 
and metabolic characteristics of the study population (n = 178) and the subsample 
from OGTT participants (n = 104) are depicted in Table 3.2. 
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3.2 Fetal HR, HRV and fetal gender  
When testing the effect of fetal gender as a potential covariate, an ANCOVA using 
gestational age as a covariate revealed a significantly higher fetal HR in female 
than in male fetuses (142.34 ± 0.74 vs. 139.46 ± 0.73 bpm, F(1) = 7.54, P = 0.007). 
The significant difference remained even after birth weight was additionally added 
as a covariate (142.11 ± 0.74 vs. 139.68 ± 0.73 bpm, F(1) = 5.33, P = 0.022). However, 
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fetal gender showed no significant difference with respect to any fetal HRV 
parameter (P > 0.2). When analysing fetal HR and HRV, we therefore included fetal 
gender as a covariate, together with gestational age and parity. 
 
3.3 Maternal weight factors 
3.3.1 Maternal HR, HRV and maternal weight factors 
No association was found between maternal heart parameters and any maternal 
weight factors. Some concerns have been raised that HRV is mainly driven by HR 
(Antelmi et al., 2004; Billman, 2013; Sacha, 2014; Tsuji et al., 1996); therefore, we 
tested the correlation between maternal HR and maternal HRV. This test confirmed 
a significant correlation between the maternal HR and all maternal HRV measures 
(P < 0.001). Further analyses were conducted for maternal HRV by adjusting for 
maternal HR. Even after adjusting for maternal HR, no significant correlation was 
noted between maternal weight factors and maternal HRV as a continuous variable 
(Table 3.4). Consideration of pre-pregnancy BMI and maternal weight gain as a 
group factor revealed no significant differences in maternal HR and HRV. 
Moreover, tests of the relationship between continuous variables revealed a 
negative correlation between pregnancy BMI and maternal weight gain (r = -0.254, 
P = 0.001). 
 
3.3.2 Fetal HR and pre-pregnancy BMI  
The ANCOVA for the four pre-pregnancy BMI groups (covariates: gestational age, 
gender and parity) revealed a significant main effect of pre-pregnancy BMI on HR 
(F(3) = 2.84, P = 0.040, Table 3.3). Post hoc analysis showed that the HR was higher 
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in fetuses of mothers with obesity than in fetuses of mothers with normal weight 
(145.00 ± 1.67 vs. 140.25 ± 0.62, P = 0.040). However, after Bonferroni-Holm 
correction, the differences did not reach significance (P = 0.024). Figure 3.1b shows 
a U-shaped pattern of fetal HR in the different pre-pregnancy BMI groups, with 
lower values in the normal weight group compared to the groups outside the 
normal weight range in both directions. Pre-pregnancy BMI as a continuous 
variable showed no significant correlation with fetal HR (Table 3.4). Image from 
Figure 3.1b has been previously published in Mat Husin et al. (2020). 
 
Given the imbalanced sample sizes for pre-pregnancy BMI groups, with a very 
small sample of underweight (UW) subjects, further analysis was performed on 
matched subsamples in two larger groups: a normal weight (NW) group and a 
combined overweight and obese (OW+OB) group. Forty-nine subjects matched in 
gestational age, gender and parity were included. A paired t-test showed a 
significantly higher fetal HR in the combined overweight and obese group than in 
the normal weight group (142.00 ± 0.83 vs. 139.25 ± 1.04, t(96) = 1.96, P = 0.050). 
The results are shown in Figure 3.1c. We additionally performed an ANCOVA with 
three groups, by excluding the UW group (NW, OW, and OB). The main effect 
remained significant (F(2) = 3.51, P = 0.032). Post hoc analysis showed a 
significantly higher fetal HR in the fetuses of the OB group than in those of the 
NW group (145.00 ± 1.67 vs. 140.29 ± 0.62, P = 0.028), but the difference was not 
significant after Bonferroni-Holm correction (P = 0.084).  
 
3.3.3 Fetal HR and maternal weight gain 
The ANCOVA containing three maternal weight gain groups (covariates: 
gestational age, gender and parity) revealed no significant difference in fetal HR 
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(F(2) = 1.20, P = 0.305, Table 3.3). Maternal weight gain as a continuous variable 
(covariates: gestational age, gender and parity) had a significant negative 
correlation with fetal HR (r = -0.138, P = 0.041, Figure 3.2a, Table 3.4). However, 
after pre-pregnancy BMI was added as an additional covariate, no significant 
correlation was found between maternal weight gain and fetal HR (r = -0.132, P = 
0.083). 
 
3.3.4 Fetal HRV and pre-pregnancy BMI 
The ANCOVA revealed no significant main effect of pre-pregnancy BMI group on 
any HRV parameter (P > 0.2, covariates: gestational age, gender and parity, Table 
3.4). For continuous variables, pre-pregnancy BMI had a positive correlation with 
the HFn component (r = 0.175, P = 0.021), and an inverse correlation with the LFn 
(r = -0.175, P = 0.021) and the LF/HF ratio (r = -0.168, P = 0.026, Figure 3.1, Table 
3.4).   
 
3.3.5 Fetal HRV and maternal weight gain 
The ANCOVA (covariates: gestational age, gender and parity) showed a significant 
main effect of maternal weight gain group on fetal SDNN and absolute LF 
component (SDNN: F(2) = 5.17, P = 0.007; LF, F(2) = 5.28, P = 0.006). Post hoc 
analysis revealed that SDNN and LF were significantly lower in fetuses of mothers 
with high weight gain than in fetuses of mothers with normal weight gain, even 
after Bonferroni-Holm correction (SDNN: 8.64 ± 0.38 vs. 10.34 ± 0.39, P = 0.006, 
after Bonferroni-Holm correction, P = 0.018 ; LF: 24.85 ± 2.65 vs. 36.54 ± 2.77, P = 
0.008, after Bonferroni-Holm correction, P = 0.024). Remarkably, the overall effect 
of the maternal weight gain group on both SDNN and LF were depicted as an 
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inverted U-shaped relationship, with lower values in weight gain lower and higher 
than the recommended range (Table 3.3, Figure 3.2b and 3.2c). Maternal weight 
gain as a continuous variable showed no significant correlation with any fetal HRV 
variable (Table 3.4). Image in Figure 3.2b has been previously published in Mat 
Husin et al. (2020). 
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Figure 3.1 Relationship between fetal HR, HRV and pre-pregnancy BMI. a. Associations 
between pre-pregnancy BMI as a continuous variable and fetal LF/HF, with r as a partial 
correlation coefficient adjusted for gestational age, parity and gender. b. HR differed 
significantly between the different pre-pregnancy BMI groups. This effect was mainly due 
to a difference between the obese and normal weight group and was not significant after 
Bonferroni-Holm correction. A U-shaped pattern appears between pre-pregnancy BMI and 
fetal HRV in overall populations. c. When case-control matched for gestational age, parity 
and gender, HR differed significantly between normal weight and overweight/obese group. 
Data presented are mean ± SEM. HR: heart rate, bpm: beat per minute, BMI: body mass 
index, UW: underweight, NW: normal weight, OW: overweight, OB: obese. Figure 3.1b has 
been previously published in Mat Husin et al. (2020). 
 
                  
        
 b.  c. 
a. 
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Figure 3.2 Relationship between fetal HR, HRV and maternal weight gain. a. Associations 
between fetal HR and maternal weight gain, with r as a partial correlation coefficient 
adjusted for gestational age, parity and gender. Significant differences between the b. 
SDNN and c. LF in fetuses of high weight gain mothers and that of normal weight gain 
mothers (significance remained after Bonferroni-Holm correction). An inverted U-shaped 
pattern appears between maternal weight gain and fetal HRVs in overall populations. Data 
presented are mean ± SEM. HRV: heart rate variability, LF/HF: ratio of low frequency to 
high frequency, BMI: body mass index, SDNN: standard deviation of normal-to-normal 
interval, LF: low frequency, ms: milliseconds. Figure 3.2b has been previously published in 
Mat Husin et al. (2020)  
 
 
 
 
 
            
 
 
 
 
b. c. 
a. 
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3.4 Maternal glucose metabolism in the fasting state 
3.4.1 Maternal weight factors and maternal metabolism 
The pre-pregnancy BMI had a positive correlation with maternal fasting glucose 
and insulin (Glucose: r = 0.198, P = 0.042, Insulin: r = 0.536, P = 0.000). As expected, 
pre-pregnancy BMI was negatively correlated with maternal insulin sensitivity (r = 
-0.350, P = 0.000). No significant correlation was observed between any measure 
of maternal fasting metabolism and maternal weight gain (Glucose: r = 0.105, P = 
0.286; Insulin: r = -0.121, P = 0.220; Insulin sensitivity: r = 0.060, P = 0.544). 
 
3.4.2 Maternal HR, HRV and maternal metabolism 
Maternal HR was significantly correlated with maternal fasting insulin (r = 0.252, 
P = 0.010) and insulin sensitivity (r = -0.218, P = 0.026). For maternal HRV 
parameters, HF was negatively correlated with maternal fasting glucose (r = -0.199, 
P = 0.040) and LF/HF had a positive correlation with maternal fasting insulin (r = 
0.193, P = 0.050). As in the previous section for the whole population, further 
analyses were conducted by including HR as covariate to exclude the influence of 
HR on HRV. After adjusting for HR, HF remained significantly correlated with 
maternal fasting glucose (r = -0.215, P = 0.029); however, no significant correlation 
remained between LF/HF and maternal fasting insulin (r = 0.084, P = 0.399). In 
addition, RMSSD and HFn now showed a negative correlation with insulin 
sensitivity (RMSSD: r = -0.203, P = 0.040; HFn: r = -0.228, P = 0.020). LFn was 
positively correlated with insulin sensitivity (r = -0.228, P = 0.020). Table 3.4 
summarizes the correlation results. 
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3.4.3 Fetal HR and maternal metabolism 
As observed for the maternal HR, the fetal HR was significantly correlated with 
maternal fasting insulin (r = 0.241, P = 0.017) and insulin sensitivity (r = -0.236, P 
= 0.020, Figure 3.3a). No significant correlation was observed between fetal HR and 
maternal fasting glucose (r = 0.169, P = 0.097). The correlation results are shown 
in Table 3.4. 
 
3.4.4 Fetal HRV and maternal metabolism 
Maternal fasting insulin had a positive correlation with HFn (r = 0.253, P = 0.012) 
and an inverse correlation with LFn (r = -0.253, P = 0.012). A positive correlation 
was noted between maternal insulin sensitivity and LFn (r = 0.269, P = 0.008), as 
well as LF/HF (r = 0.220, P = 0.030), whereas a negative correlation was observed 
with HFn (r = -0.269, P = 0.008). As pre-pregnancy BMI was shown to be 
significantly associated with maternal insulin sensitivity, the test was repeated to 
control for the influence of pre-pregnancy BMI. The correlation remained 
significant for HFn (r = -0.222, P = 0.031) and LFn (r = 0.222, P = 0.031), but not for 
LF/HF (r = -0.199, P = 0.054). No associations were detected between fetal HRV and 
maternal fasting glucose. The results are presented in Table 3.4. 
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Figure 3.3 Relationship between maternal insulin sensitivity, fetal HR and HRV.                              
a. Associations between fetal HR and maternal insulin sensitivity with r as a partial 
correlation coefficient adjusted for gestational age, parity and gender. b. Fetal HRV 
mediating the association between maternal insulin sensitivity and fetal HR. LF/HF: the 
ratio of low to high frequency, CI: confidence intervals. Figure 3.3b has been previously 
published in Mat Husin et al. (2020)  
 
 
 
 
 
 
 
a. 
b. 
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Fetal HRV mediating the association between maternal insulin sensitivity and 
fetal HR 
We proposed fetal LF/HF as another possible mediator in the association between 
maternal insulin sensitivity and fetal HR. As illustrated in Figure 3.3b, fetal LF/HF 
significantly mediated the maternal insulin sensitivity in predicting fetal HR (ab = 
-10.383, 95% CI [-26.613, -2.369]). The direct relationship between maternal insulin 
sensitivity and fetal HR was significant (c = -49.525, P = 0.020), but was reduced 
and no longer significant after adding fetal LF/HF as the mediator (c’ = -39.141, P 
= 0.065). Image in Figure 3.3b has been previously published in Mat Husin et al. 
(2020). 
 
3.5 Birth weight 
3.5.1 Fetal HR, HRV and birth weight 
Fetal HR was significantly negatively correlated with birth weight (r = -0.187, P = 
0.013). No correlation was observed between any fetal HRV measure and birth 
weight.  
 
Fetal HR mediating the association between fetal HRV and birth weight 
In partial correlation, only fetal LF/HF was significantly correlated with fetal HR (r 
= -0.157, P = 0.039). Here, we tested the possibility of a mediation relationship 
between fetal HR and birth weight via fetal HR. As depicted in Figure 3.4a, a 
significant indirect association was apparent between fetal LF/HF and birth weight 
mediated by fetal HR (ab = 3.668, 95% CI [0.124, 10.470]). The association between 
fetal LF/HF and birth weight was not significant (c = 7.058, P = 0.470), and 
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remained not significant with further reduced effect size, after adding fetal LF/HF 
as the mediator (c’ = 3.390, P = 0.728). 
 
3.5.2 Fetal HR, maternal weight gain and birth weight 
Fetal HR mediating the association between maternal weight gain and birth 
weight 
Based on the inter-correlation between parameters from the results of partial 
correlation, we proposed that maternal weight gain predicts birth weight through 
fetal HR as the mediator. This model, as shown in Figure 3.4b, revealed a 
significant indirect association between maternal weight gain and birth weight, 
through fetal HR (ab = 58.931, 95% Cl [4.809, 159.590]), with a significant 
relationship shown for maternal weight gain predicting fetal HR (a = -5.208, P = 
0.041) as well as for fetal HR predicting birth weight (b = -11.316, P = 0.020). No 
significant relationship was indicated for the total effect between maternal weight 
gain and birth weight (c = 180.908, P = 0.267). The association was reduced after 
adding fetal HR as the mediator (c’ = 121.977, P = 0.453), suggesting that fetal HR 
mediates the relationship between maternal weight gain and birth weight.   
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Figure 3.4 Relationship between maternal weight gain, fetal HR, HRV and birth weight.               
a. Fetal HR mediating the association between fetal HRV and birth weight. b. Fetal HR 
mediating the association between maternal weight and birth weight. CI: confidence 
intervals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
a. 
b. 
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3.6 Fetal HR regression models 
In this section, the prediction performance of fetal HR regression models is 
compared by three different set of features: Clinical variables, maternal HRV and 
combined clinical/maternal HRV. Model predictions on the testing dataset are 
examined based on the correlation between the predicted and actual values. The 
prediction performance of the tuned model and the tuned model with reduced 
number of features are then evaluated. The regression performance from the 
results of the cross-validation are examined.  
 
Decision tree: In each set of features, when we trained the regression model with 
the decision tree, the tree did not find a good split and took the average of the 
fetal HR outcome as the predictor. Therefore, we excluded the results from the 
decision tree. The results for the performance of Linear regression (Linear), 
Support Vector Machine (SVM), Random Forest (RF), tuned RF and tuned RF with 
reduced features are reported. 
 
3.6.1 Feature set of clinical variables 
Prediction performance on testing dataset 
The predicted values of the RF model were significantly correlated with the actual 
fetal HR values (r = 0.378, P = 0.036). Other models showed no significant 
correlation between the predicted and the actual fetal HR. Given that the RF model 
showed the prediction of fetal HR closest to the actual fetal HR values, we 
examined the two RF model parameters; mtry and ntree, to find their best values 
to improve the model prediction performance. Using “grid search”, we obtained 
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the best value of mtry = 2, which is the same value used in the original RF model. 
Tuned RF model with ntree = 200 had a lower MAE (Figure 3.5a) and RMSE 
compares with the model using ntree = 1000 (ntree used in the original RF model). 
Therefore, the smaller value of ntree was chosen and the prediction performance 
of the tuned RF model was tested on the testing dataset. The model prediction was 
significantly correlated with the actual fetal HR (r = 0.360, P = 0.049); however, the 
prediction of the original RF was better than the tuned RF model. The reduction in 
the significance level was expected due to the lower number of trees used in the 
tuned RF model in comparison with the original RF model.  This can be seen from 
the cross-validation results as shown in Figure 3.5. The original RF model with 
ntree = 200 had a higher MAE and lower r2 compares with the tuned RF model 
using the same number of trees. For ntree = 1000, the MAE was lower in the tuned 
RF, however the r2 are similar.  
 
To test the model with a smaller number of features, we excluded 2 of the 11 
features with a cut-off of importance score lower than zero: parity and maternal 
height (the importance score is shown in Table 3.7). The model fitting using only 
9 features was repeated on the previously tuned RF model. The prediction 
performance remained significant (r = 0.382, P = 0.034). The prediction results are 
detailed in Table 3.5. The predictions of the three RF based models (RF, tuned RF 
and tuned RF with reduced features) and the linear model are presented in Figure 
3.6.  
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Figure 3.5. Evaluation of clinical variables based model between original RF model and 
tuned RF model from cross-validation.  a. mean values of MAE and b. mean values of r2 
versus number of trees.  
 
Model prediction performance from cross-validation  
The ANCOVA for the five models using clinical variables showed a significant main 
effect on MAE (F(4) = 6.75, P < 0.001. Post hoc analysis revealed a significantly 
lower MAE for all four models; RF (5.16 ± 1.10, P = 0.002), SVM (5.00 ± 1.01, P < 
0.001), tuned RF (5.16 ± 1.10, P = 0.002) and tuned RF with reduced features (5.26 
± 1.13, P = 0.011) than for the linear model (5.75 ± 1.15). All results remain 
significant even after Bonferroni-Holm correction. The cross-validation results are 
shown in Table 3.6. 
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Figure 3.6 Regression using a feature set of clinical variables. Predicted versus actual fetal 
heart rate values using testing dataset for the a. linear model, b. random forest model, c. 
tuned random forest model and d. tuned random forest model with a reduced number of 
features. 
 
3.6.2 Feature set of maternal HRV 
Prediction of the testing dataset and model performance from cross-validation 
No model based on maternal HRV variables showed significant correlation between 
the predicted and actual fetal HR values (Linear: P = 0.853, SVM: P = 0.403, RF: P = 
0.338, Table 3.5). We tuned the RF model using ntree = 100 and mtry = 2 and 
reduced the number of features from 8 to 6 features based on the scores of 
variable importance. Correlations between the predicted and actual fetal HR values 
remained not significant even after the hyperparameter tuning and features 
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reduction (Table 3.5). The ANOVA showed no significant difference of MAE and 
RMSE between the five models (Table 3.6). 
 
3.6.3 Feature set of combined clinical/maternal HRV 
Prediction performance of the testing dataset 
The predicted values of the RF model were significantly correlated with the actual 
fetal HR values (r = 0.376, P = 0.037). Models using linear regression and SVM 
showed no significant correlation between the predicted and the actual values of 
the fetal HR. The prediction results are shown in Table 3.5. We tuned with the RF 
model, which was the model with the best prediction performance. The value of 
the ntree = 100 and mtry = 2 were chosen because they had the lowest RMSE and 
MAE (the original RF model used ntree = 1000 and the same mtry value). When the 
tuned RF model was tested on the testing dataset, we observed that prediction was 
significantly correlated with the actual fetal HR (r = 0.397, P = 0.027). The 
prediction performance was better than the original RF model. In an attempt to 
improve the model prediction performance, we reduced the number of features 
from 19 to 13 based on the scores of variable importance. A zero cut-off of the 
importance score was used for feature reduction (Table 3.7). We then performed 
the model fitting again on the previously tuned RF model. The prediction was no 
longer significantly correlated with the actual fetal HR (r = 0.312, P = 0.088). 
Predictions of the three RF based models and the linear model are presented in 
Figure 3.7.  
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Model performance from cross-validation 
An ANCOVA revealed a significant main effect of MAE and RMSE between the 
models of the combined clinical/maternal HRV feature set (MAE: F(4) = 12.51, P < 
0.001 , RMSE: F(4) = 5.64, P < 0.001). Post hoc analysis showed that the MAE was 
significantly lower for all models (all P < 0.001) compared to the linear model. The 
RMSE values were significantly lower for all models (all P < 0.005) than for the 
linear model. All results remained significant even after Bonferroni-Holm 
correction. The results of cross-validation are listed in Table 3.6.  
 
 
Figure 3.7 Regression using a combined clinical/maternal HRV feature set. Predicted versus 
actual fetal heart rate values using testing dataset for the a. linear model, b. random forest 
model, c. tuned random forest model and d. tuned random forest model with a reduced 
number of features. 
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Chapter 4 
General discussion 
4.1. Discussion of the main findings 
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Changes in pre-pregnancy BMI, maternal weight gain and maternal insulin 
sensitivity alter fetal HR and HRV 
 
Our results provide evidence supporting our first hypothesis that variations in pre-
pregnancy BMI, weight gain during pregnancy and maternal insulin sensitivity can 
alter the development of fetal ANS. Table 4.1 summarizes the findings. We found 
a significant effect for the four pre-pregnancy BMI groups with regard to fetal HR. 
Normal weighted mothers had the lowest fetal HR. However, the point should be 
borne in mind that the normal fetal HR is in the range of 120 to 160 bpm (Pildner 
von Steinburg et al., 2013). Although the mean HR in the fetuses of mothers with 
obesity was still in the normal range (the mean fetal HR is 142 bpm), the value was 
higher than in the fetuses of their lean counterparts. The fetuses in the 
underweight group showed the same pattern, albeit not significant, which is 
possibly due to the small sample size in the underweight group. This finding 
indicates a U-shaped relation, suggesting that pre-pregnancy BMI should be in the 
normal range to prevent alterations in fetal HR. Furthermore, with regard to 
maternal weight gain, fetal HRV was lower in fetuses of mothers with high 
maternal weight gain than in those who gained weight within the recommended 
range, such that the SDNN was reduced by 16.5 percent. Although the maternal 
weight gain group was computed according to pre-pregnancy BMI, we still 
observed a reduction in HRV in fetuses of mothers with high maternal weight gain. 
This is in contrast to a recent finding by Voegtline et al. (2016), in which maternal 
weight gain was reported to have no predictive power on fetal HR and fetal HRV 
beyond pre-pregnancy BMI. This reduction in fetal HRV in mothers with high 
weight gain is an indicator of an adverse effect on fetal ANS, since reduced fetal 
HRV is also observed in IUGR (Nijhuis et al., 2000) and GDM fetuses (Fehlert et al., 
2016).  
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In general, the lower the pre-pregnancy BMI, the more weight gain during 
pregnancy is expected, and the ranges of a recommended weight gain for women 
with normal pre-pregnancy BMI are higher compared with women with obesity. 
Therefore, the observed relationship between pre-pregnancy BMI and fetal HR 
versus the association between maternal weight gain and fetal HRV is consistent 
with the previously stated increased HR in women with obesity (as they probably 
had a lower weight gain during pregnancy). Therefore, an increase in pre-
pregnancy BMI is associated not only with fetal ANS changes but also with 
increased maternal weight gain, even in women with normal pre-pregnancy BMI. 
Different, potentially adverse intrauterine environments—whether pre-pregnancy 
underweight or obesity—as well as inadequate or excessive maternal weight gain 
may therefore result in altered trajectories of normal ANS development. HR and 
HRV alterations are driven by sympathetic and parasympathetic activity. The U-
shaped and the inversed U-shaped curves in the effect of pre-pregnancy BMI and 
maternal weight gain could indicate immaturity of fetal ANS, implicating an 
anomalous ANS development in less favourable intrauterine environments.  
 
In healthy fetal development, fetal HR decreases gradually with advancing 
gestational age (Pildner von Steinburg et al., 2013; Serra et al., 2009). Maturation 
of the parasympathetic vagal tone commences at approximately 31 weeks of 
gestation and continues after birth (Nederend, Jongbloed, de Geus, Blom, & ten 
Harkel, 2016). This stronger parasympathetic influence causes a reduction in HR 
and an increase in HRV during gestation (Pildner von Steinburg et al., 2013; 
Schneider et al., 2009; Van Leeuwen et al., 2013; Wakai, 2004). Higher fetal HR and 
lower fetal HRV can be due either to an increase in sympathetic regulation or to a 
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decrease in parasympathetic regulation. Since the majority of our study population 
was investigated before 31 weeks of gestation (62%, mean gestational age 30.4 
weeks, ranging between 26 and 38 weeks), the observed increase in fetal HR in 
mothers with obese/overweight pre-pregnancy BMI is most probably influenced by 
activity in the sympathetic rather than in the parasympathetic nervous system. In 
addition, the observed effects on fetal HRV are seen in measures associated with 
both sympathetic and parasympathetic activity, but not in those associated 
primarily with parasympathetic activity. This indicates that the observed 
alterations are very probably the result of enhanced sympathetic nervous system 
activity.  
 
In addition, reduced maternal insulin sensitivity was indirectly associated with an 
increased fetal HR through fetal HRV, suggesting that the fetuses of healthy 
mothers with decreased insulin sensitivity are already exposed to a less favourable 
metabolic environment. As of now, only one study has studied the relationship 
between fetal heart parameters and maternal insulin sensitivity, but no association 
was observed (Dewi et al., 2017). These researchers suggested that their sample 
size (44 samples) was too small to show an effect. The correlation analysis in the 
present work revealed that decreased maternal insulin sensitivity and increased 
maternal fasting insulin are associated with an increased maternal HR and fetal 
HR. Furthermore, HR is higher in mothers with GDM than in normoglycemic 
mothers (Fehlert et al., 2016), and HR was higher in the fetuses of mothers with 
GDM both during the fasting state and after an oral glucose load. At 120 minutes 
after a glucose load, the SDNN, as the measure of overall variability, was lower in 
fetuses of mothers with GDM. The researchers also suggested that the decrease in 
the fetal HR in fetuses of mothers with GDM might be a reflection of fetal insulin 
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resistance (Fehlert et al., 2016). Based on these observations, the increased 
maternal and fetal HR associated with lower maternal insulin sensitivity and 
higher maternal fasting insulin already seen in normoglycemic mothers could be 
related to higher sympathetic activity in both mother and fetus. 
 
Fetal HR mediates the relationship between maternal weight gain and birth 
weight 
The role of MAM influences and fetal ANS on neonatal outcome, specifically 
whether fetal HR is mediating the relationship between maternal weight gain and 
birth weight, would be interesting to know. The absence of a linear association 
between maternal weight gain as a continuous variable and birth weight indicated 
that maternal weight gain has no association with the birth weight. However, 
mediation analysis revealed a significant effect of maternal weight gain on birth 
weight after adding fetal HR as the mediator. In other words, an increase in 
maternal weight gain associated with an increase in birth weight, but indirectly 
through the decrease in fetal HR. Based on the birth weight guidelines from Erich-
Saling Institute of Perinatal Medicine (2013), the majority of fetuses in this study 
have birth weights within the normal recommended range (97.8%, mean birth 
weight 3388 gram, recommended range is from 2500 to 4499 gram). The mean 
fetal HR (96.7 %, mean fetal HR 140.9 bpm) was also within the normal range 
(Pildner von Steinburg et al., 2013). Nonetheless, the fetal HR mediated the 
association between maternal weight gain and birth weight. In an impaired 
environment, the fetal ANS control may adapt to compensate for the changes in 
metabolism, perhaps through alterations in the fetal HR. This would appear to 
indicate that high sympathetic nervous system activity in fetuses may be involved 
in the fetal growth that is reflected in birth weight. Additionally, this finding 
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provides further supporting evidence that an immature ANS in the fetus may be 
an important key linking the increased birth weight and large-for-gestational-age 
offspring seen in women with excessive maternal weight gain. In the second 
mediation model on birth weight, besides maternal weight gain, the fetal HR also 
mediates the relationship between fetal HRV and birth weight. Birth weight is 
assumed to also have an optimal range and has a U-shaped relationship with fetal 
HR.  
 
Pre-pregnancy BMI is the driving factor of fetal HR 
The regression analysis using the advanced machine learning method showed that 
pre-pregnancy BMI has a major impact on the fetal HR and the impact was stronger 
than the maternal weight gain during pregnancy. Focusing first on the technical 
aspects of model performance, the results from both the clinical variables and the 
combined clinical/maternal HRV features show that the RF model outperforms 
multiple linear regression. The models successfully predicted the fetal HR as 
representing the complexity and dynamics of fetal ANS. Even clinical features 
alone—including multiple clinical variables such as gestational age, maternal 
weight and metabolic measures—were able to predict fetal HR.  
 
Given the best prediction performance of RF in the two feature sets (clinical 
variables and combined clinical/maternal HRV), model tuning was performed by 
choosing the best tree depths for making the prediction. The tuned model in the 
combined clinical/maternal HRV based model with a smaller number of trees 
produced an even better prediction than the clinical variable based model. By 
limiting the number of trees to 100 (which is the best total number of branches 
grows after each split), the forest is less deep, thereby increasing the model 
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generalization. We further reduced the complexity of the model by choosing a cut-
off of zero for the importance score to filter out the less important features. With 
only nine features, the clinical variables-based model achieved a higher accuracy 
than the model with thirteen features in the combined clinical/maternal HRV.  
 
During training, the model learned the patterns in the training dataset to make 
predictions, including the data that do not contribute to the predictive value. Even 
though in the cross-validation the SVM showed a similar performance to that of 
the RF model, the correlation results between prediction and the actual fetal HR 
values indicated that the RF model could describe the fetal ANS better than the 
SVM model. The RF technique probably produced a prediction closest to actual 
values compared to other assessed techniques because of the generalization 
created from the random sampling of subset and the selection of the features to 
make the split at each tree node. In several cross-validation folds using the 
decision tree algorithm, fetal HR values in the test subset were not within the range 
of the training set. In these cases, the decision tree could not find the best split 
and thus, took the average of fetal HR as the prediction outcome. The error metrics 
could not be calculated for these particular folds because the variance of the 
prediction becomes zero.  
 
From the ranking of the variable importance score, pre-pregnancy BMI has the 
largest impact on the prediction performance of the fetal HR models (Table 3.5). 
Maternal weight gain appeared to be among the least important features, with a 
negative importance score. After testing for collinearity, only maternal age, pre-
pregnancy BMI and gestational age had significant correlations with maternal 
weight gain, but the correlations were low (all parameters had r < 0.25). Moreover, 
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the RF algorithm produces diverse sets of trees and automatically removes the 
interaction and association between the features through the random sampling of 
features in the subunit of trees (Strobl et al., 2009). Therefore, the low importance 
of maternal weight gain in the model may not be due to collinearity between the 
included variab21les in the models. A possible reason could be that, among the 
MAM factors, a factor before pregnancy has a stronger influence than that factor 
during pregnancy in predicting the fetal HR. The importance of weight before 
pregnancy compared to weight during pregnancy has been reported in many 
studies (Kuzawa, 2005; Van Lieshout, Taylor, & Boyle, 2011). Among the maternal 
HRV features, RMSSD appeared to have the greatest on the fetal HR and was among 
the top features in the combined clinical/maternal HRV model. However, no 
maternal HRV-based model was able to predict the fetal HR even after the model 
tuning. When we combined maternal HRV with clinical features (clinical/maternal 
HRV), the model prediction performance became similar to the clinical variables 
based model. By integrating clinical variables like pre-pregnancy BMI, gender and 
maternal fasting insulin in the fetal HR model, we were able to predict fetal HR 
with high accuracy, even without maternal HRV. Furthermore, this finding also 
showed that maternal HRV features alone play a less important role than the MAM 
factors in the development of fetal ANS.  
 
Therefore, the RF model using the nine most relevant features can be concluded 
to best describe the fetal HR. Fetal HR is thus predicted by the following variables: 
pre-pregnancy BMI, maternal fasting insulin, insulin sensitivity, gravidity, maternal 
age, maternal fasting glucose, gestational age and maternal weight gain, with pre-
pregnancy BMI being the strongest influence on the fetal HR. From the ranking of 
variable importance, maternal glucose metabolism (fasting insulin and insulin 
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sensitivity) also has an important influence on the fetal HR as a maternal metabolic 
factor during pregnancy.  
 
Fetal HR differs between genders 
Female fetuses had a higher HR than the male fetuses, but no gender difference 
was detected for fetal HRV. The effect of gender on fetal HR appeared to be in line 
with some data shown previously (DiPietro et al. (2015), but other studies have 
found no gender differences in fetal HR (Bracero et al., 2016; Druzin et al., 1986; 
Fleisher et al., 1997; Genuis et al., 1996; Lange et al., 2005; Ogueh & Steer, 1998). 
Small sample sizes or different inclusion criteria might be the reasons for the 
inconsistencies. The significant gender difference in fetal HR might reflect 
variations in behavioural and neurological development by gender during 
gestation (Buss et al., 2009). Thus, in all fetal HR and HRV analyses of this work, 
gender has been included as a covariate, together with gestational age and parity. 
This additional observation of the gender related to fetal HR is important, as it 
would influence findings in future studies. Hence, taking gender into account as a 
covariate might be relevant in future fetal HR and HRV analyses. 
 
4.2. Interconnections between maternal weight, weight 
changes and metabolism, fetal ANS and birth weight 
 
To summarize and connect the main findings, Figure 4.1 presents the relationships 
connecting MAM variables, fetal ANS and birth weight.  
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Figure 4.1 Fetal ANS and its association with pre-pregnancy BMI, maternal weight gain, 
maternal insulin sensitivity and birth weight. Only associations from correlation and 
mediation analyses are included in the overall relationship. 
 
The relationships shown in the figure indicate two paths linking the factor before 
pregnancy (pre-pregnancy BMI) and the factors during pregnancy (maternal insulin 
sensitivity and maternal weight gain), which both connect to the birth weight 
through the fetal ANS. The first path, “Path ISI”, begins with the association of pre-
pregnancy BMI and the maternal insulin sensitivity, through fetal HRV as well as 
fetal HR and finally birth weight. Through path ISI, for example, a mother with 
obesity and lower insulin sensitivity (i.e. insulin resistance) would probably have 
an associated lower fetal HRV and therefore might also show an association with 
higher fetal HR. This overall relationship might play a role in the decreased birth 
weight. The second path, “Path MWG”, begins with the relationship between pre-
pregnancy BMI and maternal weight gain, as well as fetal HR and finally birth 
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weight. For the path MWG (i.e. a mother with pre-pregnancy obesity), the lower 
weight gain might be associated with an increase in the fetal HR and, at the end, 
might probably be associated with a decrease in the birth weight.  
 
Interestingly, an increase in the pre-pregnancy BMI through both paths was 
associated with signs of adverse fetal ANS, as indicated by an increase in the fetal 
HR and/or a decrease in the fetal HRV. However, both paths show a low birth 
weight as the outcome from a mother with pre-pregnancy obesity. This contrasts 
with the evidence seen among mothers with pre-pregnancy obesity associated with 
offspring obesity (Leonard et al., 2017; Mamun et al., 2014; Nehring et al., 2013). A 
point that should be taken into account is that the majority of fetuses in this 
sample had birth weights within the normal recommended range (97.8%, mean 
birth weight 3388 g, the recommended range is from 2500 to 4499 g). We 
suspected that the relationship between fetal HR and birth weight is not linear.  
 
Combining the interconnections and the findings using machine learning 
approach, the path ISI appears to play a more important role in the programming 
of the fetal ANS by pre-pregnancy obesity compares to the path MWG. Pre-
pregnancy BMI, followed by maternal insulin sensitivity, are the key factors 
associated with fetal ANS, while maternal weight gain is the least important factor. 
Maternal weight gain appeared to be the least important factor not only in the 
winning model (clinical variables) but also in the other models combining all 
features (clinical/maternal HRV) as well. A longitudinal study across pregnancy 
showed that the factor before pregnancy is more important than the factor during 
pregnancy in representing the intrauterine environment (Hellmuth et al., 2017). 
Furthermore, Gluckman pointed out that nutrient-dependent signalling (such as 
 
74  |    G e n e ra l  d i s c uss io n  
 
insulin-like growth factor) responds to slow changes in maternal metabolism 
rather than to acute changes (2010). Maternal long-term environmental signalling 
also appears to be an important indicator for the developing fetus (Kuzawa, 2005).  
 
In the overall relationship, exposure of fetal ANS to over-nourished condition like 
high pre-pregnancy obesity, low maternal weight gain and low maternal insulin 
sensitivity, during fetal development associated with the development at birth - a 
reduced birth weight. The observed relationship in our findings (as shown in 
Figure 4.1) appeared to match with the model proposed by Kuh, Ben-Shlomo, 
Lynch, Hallqvist, and Power (2003), “critical period model”. The researchers 
proposed the model to explain the development of adult disease originating from 
exposure of the structure/function of organs and tissues/body systems during a 
sensitive period of early development. This model served as a basic concept of the 
DOHaD hypothesis (Gluckman & Hanson, 2006; Gluckman et al., 2010). 
 
Programming of fetal ANS related to pre-pregnancy obesity and maternal 
insulin resistance  
To our knowledge, no previous study has analysed the relationship between fetal 
HR and pre-pregnancy BMI and maternal insulin sensitivity in healthy pregnant 
mothers. Studies in offspring of mothers with obesity showed that pre-pregnancy 
BMI is associated with higher insulin levels (Gaillard et al., 2014), but no effect was 
found on the child’s resting HRV (Gademan et al., 2013). The mechanism that could 
explain how pre-pregnancy BMI and maternal glucose metabolism may lead to 
changes in fetal HR is not known. The significant association observed between 
maternal HR and maternal insulin sensitivity and maternal fasting insulin (as 
shown in Chapter 3), and the maternal RMSSD appeared as a second important 
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factor after pre-pregnancy BMI in the fetal HR regression model with combined 
clinical/maternal HRV features. This suggests that maternal ANS probably plays 
some role in the overall relationship connecting pre-pregnancy BMI, maternal 
insulin sensitivity and the fetal ANS. Exposure to pre-pregnancy obesity together 
with insulin resistance may program fetal ANS during early development, thereby 
possibly interrupting the normal fetal metabolic environment. According to the 
Pedersen hypothesis, fetal growth is related to a higher transfer of glucose through 
the placenta, thus stimulating the release of insulin in the fetus and resulting in 
fetal macrosomia (P. M. Catalano & Hauguel-De Mouzon, 2011; Pedersen, 1971). A 
higher glucose level in pre-pregnancy obese and insulin resistant mothers causes 
the transportation of glucose through placental barrier to the fetus (Vogt et al., 
2014). The ANS is responsible for regulation of energy and glucose homeostasis 
(Marino, Xu, & Hill, 2011); therefore, an increase in the  sympathetic activity (i.e. an 
increase in the fetal HR) might be a mechanism for adaptation to the higher glucose 
environment. In turn, it possibly leads to an increase in insulin secretion in the 
fetus and may interrupt the normal fetal metabolic development. 
 
4.3. Potential mechanism and implication 
Hyperglycemia-hyperinsulinemia 
In healthy pregnancies, the basal fetal HR increases and the fetal HRV decreases 
in a high glucose environment after glucose ingestion (Gillis, Connors, Potts, 
Hunse, & Richardson, 1992; Weissman, Goldstick, Geva, & Zimmer, 2003; Zimmer, 
Paz, Goldstick, Beloosesky, & Weiner, 2000). The assumption made in the present 
study is that the observed changes in fetal HR and HRV are due to an excess of 
glucose in the maternal circulation, which then elevates the glucose transport 
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across the placenta, even in normoglycemic mothers who were obese pre-
pregnancy. The increase in sympathetic activity could also be a fetal response to 
stress imposed by high glucose. According to the Pedersen hypothesis, 
hyperglycemia in mothers can cause an increase in fetal insulin secretion, thus 
resulting in fetal hyperinsulinemia (Pedersen, 1971). Cohen showed 
hyperinsulinemia from insulin infusion leads to a high fetal HR in fetal lambs; this 
may indicate a direct effect of insulin on the peripheral sympathetic nerves (Cohen, 
Piasecki, Cohn, Susa, & Jackson, 1991). Human studies in healthy adults also 
support this assumption, as acute insulin stress exerted by a hyperinsulinemic 
euglycemic clamp has been shown to reduce parasympathetic influence and 
increase sympathetic activity (Bellavere et al., 1996; Van De Borne, Hausberg, 
Hoffman, Mark, & Anderson, 1999). Fetal hyperinsulinemia may therefore play 
some role in the increased fetal HR in the fetuses of mothers with pre-pregnancy 
obesity. A recent suggestion has been made that insulin resistance and BMI, rather 
than the insulin level, are the main influencers of autonomic cardiac control in 
adults (Valensi, Chiheb, & Fysekidis, 2013). Whether this also is similar in the 
offspring of mothers with obesity remains to be investigated.  
 
Delayed ANS maturation 
The progress of the normal fetal ANS maturation is reflected by a decrease in fetal 
HR and an increase in fetal HRV with advancing gestation, indicating lower 
sympathetic activity and higher parasympathetic activity (Pildner von Steinburg et 
al., 2013; Serra et al., 2009; Van Leeuwen et al., 1999; Wakai, 2004). The current 
findings show that changes in nutrition in utero in relation to MAM factors alter 
the autonomic fetal cardiac activity. In particular, increases in pre-pregnancy BMI 
and decreases in maternal insulin sensitivity are associated with an increased fetal 
 
4  G e ne r a l  d i s cu ss i on                       |  77 
 
HR and decreased fetal HRV. The alteration of fetal HR and HRV in mothers with 
pre-pregnancy obesity and insulin resistance might indicate a disturbance in the 
normal trajectory of fetal ANS maturation. Considerable data support this 
hypothesis. For example, a recent fMEG study showed that GDM resulted in a high 
fetal HR during the fasting state and a low fetal HRV postprandially during OGTT 
(Fehlert et al., 2016). Other studies have reported that GDM was associated with a 
high baseline fetal HR (Costa et al., 2009; Sirico et al., 2019). Conversely, 
inadequate intrauterine nutrition in IUGR fetuses elicited a similar response of the 
fetal HR and HRV (Bekedam et al., 1987; Nijhuis et al., 2000; Schneider et al., 2006). 
The present findings are in agreement with previous observations of lower fetal 
HRV in mothers with pre-pregnancy obesity (Voegtline et al., 2016). Therefore, we 
suspect that excessive intrauterine nutrition due to changes in pre-pregnancy BMI 
and insulin sensitivity may have important implications in the maturation of the 
fetal ANS. As the fetal ANS can be programmed during fetal life, fetal adaptation 
to these nutritional changes during development may disturb the normal 
maturation of the ANS.  
 
Insulin resistance in fetuses of mothers with pre-pregnancy obesity – a possible 
missing mediator in the overall relationship  
Women with obesity enter pregnancy with higher insulin resistance than normal 
weight women and, due to pregnancy, the insulin resistance further increases with 
gestational age (P. Catalano & deMouzon, 2015; P. M. Catalano, Huston, Amini, & 
Kalhan, 1999). The combination of pregnancy and obesity generates a 
dysregulation in metabolism that leads to a pathological state of insulin resistance 
in mothers. In the proposed inter-relationship (as shown in Figure 4.1), mothers 
with pre-pregnancy obesity and in the state of increased insulin resistance have 
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fetuses with an altered fetal ANS. An alteration in the fetal ANS could also be 
associated with the insulin resistance in the fetus that is missing in the overall 
relationship. This suggestion is supported by the Landsberg hypothesis, which 
proposes that insulin resistance in obese individuals with sympathetic stimulation 
is a mechanism for limiting weight gain, but it leads to an increase in blood 
pressure (Landsberg, 1990, 2001). Specifically, the hypothesis states that “insulin 
resistance serves to stabilize body weight by limiting fat stored in adipose tissue 
as well as via the sympathetic nervous system, driving thermogenic mechanisms 
to restore energy balance”. The fetuses of mothers with pre-pregnancy obesity in 
the proposed relationship who appeared to have lower birth weights agree with 
this hypothesis. In another observation related to this work, Catalano reported 
that infants of mothers with obesity have higher peripheral insulin resistance (P. 
M. Catalano et al., 2009) and the increased fetal insulin resistance was closely 
associated with increased neonatal body fat mass; however, they did not test the 
association with the birth weight. Whether the alteration in fetal ANS is a 
mechanism to prevent weight gain (as proposed by Landsberg) and/or leads to 
higher fat mass (as observed by Catalano) remains to be established. 
 
Furthermore, recent findings have suggested that insulin resistance in the brain 
controls not only the body weight, but also glucose metabolism (Hallschmid & 
Schultes, 2009). Insulin resistance in the fetal brain has been proposed as the cause 
of the alteration seen in fetal CNS in insulin-resistant mothers (Linder et al., 2014; 
Linder et al., 2015). A study of adults with obesity showed that insulin apparently 
influenced parasympathetic heart activity and hypothalamus activation, 
suggesting an action of insulin in the brain (Heni et al., 2014). Alterations in 
autonomic cardiac function that precede insulin resistance have been found in 
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adults, and this might also be true in fetuses (Chang et al., 2010; Masuo, Mikami, 
Ogihara, & Tuck, 1997; Valensi et al., 2013). Based on this evidence and many 
theories, a possible explanation is that fetal insulin resistance, as well as fetal fat 
mass, could be the missing factors in the proposed relationship that links the 
changes in the fetal ANS towards sympathetic predominance. The state of insulin 
resistance in the fetus as either a cause or a consequence of the fetal ANS alteration 
is a subject for future investigation.  
 
4.4. Strengths, limitations and suggestions for future 
research 
 
One of the strengths of this work is the use of a unique fMEG device that can non-
invasively measure the heart signals of the fetus (Preissl et al., 2005), thereby 
providing a window into fetal ANS development. The fetal HRV recorded with fMEG 
can be used to monitor fetal ANS, as has been demonstrated in previous studies 
(Brändle et al., 2015; Fehlert et al., 2016). The present work confirmed that the 
fMEG device is an excellent tool for detecting changes in fetal ANS associated with 
maternal metabolism in normoglycemic pregnancies, concerning the potential 
effect of intrauterine metabolic environment on fetal programming.  
 
The analysis included the use of mediation analysis, which is more complex than 
linear regression and allows testing of mediation factors in the relationship of 
interest. Moreover, the implementation of advanced machine learning techniques 
has provided additional useful information, especially in the study of noisy and 
complex biological signals. The observed effect of gender on fetal HR has been 
replicated (DiPietro et al., 2015), suggesting that gender effect should be taken into 
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account in future fetal HR and HRV studies. Even though the work in this 
dissertation includes a large population, it consists of cross-sectional 
measurements. Additionally, the reported significant correlations show only weak 
linear relationships between the maternal and fetal factors, despite our large 
sample size covering a wide range of maternal values. The grouped analyses 
indicated non-linear relationships, which should be taken into account in further 
studies. To advance the understanding of the features responsible for the 
development of ANS and to draw valid conclusions, long-term studies with HRV 
measures in offspring throughout childhood are necessary. This is important for 
tracking changes during development and for observing the relevance of pre-
pregnancy BMI, maternal weight gain and maternal insulin sensitivity on the ANS 
and its contribution to the development of obesity in the offspring during infancy 
and childhood.  
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Chapter 5 
Conclusion 
In conclusion, these findings suggest that an alteration occurs in the development 
of fetal ANS in response to changes in pre-pregnancy BMI, maternal weight gain and 
maternal insulin sensitivity. These alterations might indicate a sign of less maturity 
in the ANS in fetuses of mothers with metabolism disturbances. The state of insulin 
resistance in the fetuses of mothers with GDM might also be true for fetuses of 
mothers with pre-pregnancy obesity and insulin resistance. The fact that fetal ANS 
mediates fetal growth suggests that ANS might potentially be one of the key features 
involved in the risk the development of disease in offspring. Hence, an alteration in 
fetal ANS during early development in relation to maternal weight, weight changes 
and maternal metabolism could have important clinical consequences in this era of 
rising obesity. Furthermore, this finding highlights the importance of pre-pregnancy 
weight which, together with maternal insulin sensitivity, could play a crucial role in 
the developmental programming of the fetal ANS. This may be an early life process 
driving maternal-fetal transmission of obesity and insulin resistance in offspring. 
High fetal HR may serve as a marker for an adverse fetal ANS status under the 
influence of pre-pregnancy weight and maternal insulin sensitivity. Maternal weight 
and metabolic factors are interconnected and connected to fetal ANS activity, so 
they might form a part of the complex relationship for fetal adaptation to the 
intrauterine environment.  
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